International Expanded-access programme of everolimus in post TKI

1
Évaluation de lévérolimus dans la vraie vie chez
un patient ayant un cancer du rein métastatique

• International Expanded-access programme of
  everolimus in post TKI
• 34 countries
• 1367 patients enrolled
• Nearly all patients undergone nephrectomy 99.6
• Majority of Clear cell carcinoma 94
• Majoriry of patients one VEGF-TKI 65.5
• Only one prior VEGF-TKI treatment 38.5
• Toxicity grade 3-4 mainly anemia (14.9)
  pulmonary symptoms